Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity ACTINOGEN MEDICAL LIMITED ABN/ARBN Financial year ended: 14 086 778 476 30 JUNE 2026 ...
Appendix 4G
Filed with ASX · · 11 pages · English
On 6ix: 6ix.com/news/appendix-4g-42
Release
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Corporate Governance Statement
- Appendix 3Y - Dr George Morstyn
- Application for quotation of securities - ACW
- Appendix 3Y-Malcolm McComas
- ACW webinar today, The future of Alzheimers treatment
Later from Actinogen Medical
- ACW Appendix 4E and 2026 annual report
- ACW FY2026 results and outlook
- Appendix 3Y-Dr Geoffrey Brooke
- Proposed issue of securities - ACW
- ACW unlisted options fully underwritten
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical